ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 570

Sleep Disturbances in Korean Patients with Ankylosing Spondylitis Are Associated with Increased Disease Activity

Hye-Jin Jeong1, Yun Sung Kim2, Chang-Nam Son3, Ji-Min Kim3 and Sang-Hyon Kim3, 1Keimyung University Dongsan Medical Center, Daegu, South Korea, 2Internal Medicine, Chosun University Hospital, Gwangju, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ankylosing spondylitis (AS) and sleep disorders, Disease Activity

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Sleep problems have been reported to be more frequent in rheumatic disease than normal population. Other studies indicate various sleep problems have been reported in ankylosing spondylitis (AS). Inadequate sleep in AS patients is associated with multiple factors including pain, fatigue, disease activity and depression. In this study, we evaluated the prevalence of sleep disturbance in Korean patients with ankylosing spondylitis, and its association with disease activity and depression.

Methods: Forty patients with AS and eighty healthy controls were included in the study. Participants completed questionnaires. Sleep quality was assessed using the Korean version of the Pittsburgh sleep quality index (PSQI). Depression was assessed by the Korean version of the Beck depression inventory second edition (BDI-2). The Bath ankylosing spondylitis disease activity index (BASDAI) and ankylosing spondylitis disease activity score-C-reactive protein (ASDAS-CRP) were used to evaluate disease activity. Patients were dichotomized into a good sleeper group (PSQI ≤ 5) and a poor sleeper group (PSQI > 5).

Results: The mean total PSQI score of patients with AS was 7.23 ± 3.84. It was higher than that of control subjects (p < 0.001). AS patients had higher scores in the subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance and daytime dysfunction components. 60% of the AS patients classified as poor sleeper group. The mean ASDAS-CRP and BDI-2 score of poor sleeper group were higher than that of good sleeper group. Significantly, higher disease activity according to ASDAS-CRP was associated with poor sleep quality and depression. Stepwise multiple regression analysis revealed that duration of morning stiffness and depression were independent risk factors that influenced poor sleep quality.

Conclusion: Sleep disturbances are prevalent amongst Korean patients with AS. Lower quality of sleep is significantly associated with higher disease activity and depression. Morning stiffness and depression were independent risk factors that influenced poor sleep quality. Therefore, evaluation and optimal management of morning stiffness and depression to improve sleep quality in patients with AS is important.


Disclosure:

H. J. Jeong,
None;

Y. S. Kim,
None;

C. N. Son,
None;

J. M. Kim,
None;

S. H. Kim,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sleep-disturbances-in-korean-patients-with-ankylosing-spondylitis-are-associated-with-increased-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology